0.21
1.87%
-0.004
Viracta Therapeutics Inc Azioni (VIRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses |
2.32%
13.88
|
13.56 | 12.47 | 12.45 | 12.21 |
Interest Income/Expense |
9.59%
0.858
|
0.949 | 0.953 | 0.921 | 0.88 |
Operating Income/Loss |
2.32%
-13.88
|
-13.56 | -12.47 | -12.45 | -12.21 |
Income/Loss From Continuing Operations Before Tax |
33.59%
-9.141
|
-13.77 | -12.60 | -12.48 | -12.21 |
Income/Loss From Continuing Operations After Tax |
33.59%
-9.141
|
-13.77 | -12.60 | -12.48 | -12.21 |
Net Income/Loss
|
33.59%
-9.141
|
-13.77 | -12.60 | -12.48 | -12.21 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
70,188%
39.32
|
0.0559 | 38.68 | 38.56 | 38.46 |
Diluted Average Shares |
70,188%
39.32
|
0.0559 | 38.68 | 38.56 | 38.46 |
Basic Earnings Per Share |
34.29%
-0.23
|
-0.35 | -0.33 | -0.32 | -0.32 |
Diluted Earnings Per Share |
34.29%
-0.23
|
-0.35 | -0.33 | -0.32 | -0.32 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):